Advertisement
Screener

AARDVARK THERAPEUTICS, INC. (AARD) Current Liabilities

2.8 / 5 stars · 68/120 Roast Me

AARDVARK THERAPEUTICS, INC. Current Liabilities

AARDVARK THERAPEUTICS, INC. (AARD) had Current Liabilities of $6.39 million as of 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Current

us-gaap:LiabilitiesCurrent · last filed 2026-08-11

  • 2026-06-30: Liabilities, Current $6.39M.
  • 2026-03-31: Liabilities, Current $11.60M.
  • 2025-12-31: Liabilities, Current $10.55M.
  • 2025-09-30: Liabilities, Current $10.74M.
Period endLiabilities, Current
2026-06-30$6.39M
10-Q · filed 2026-08-11
2026-03-31$11.60M
10-Q · filed 2026-05-07
2025-12-31$10.55M
10-Q · filed 2026-08-11
2025-09-30$10.74M
10-Q · filed 2025-11-13
2025-06-30$10.31M
10-Q · filed 2025-08-13
2025-03-31$5.98M
10-Q · filed 2025-05-14
2024-12-31$4.93M
10-K · filed 2026-03-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Immuneering Corp (IMRX)United States$0.113B-12.51
Quantum Cyber N.V. (QUCY)$0.113B
MEDICINOVA INC (MNOV)United States$0.130B-6.04
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31